kneat.com, inc.

KSI

CA4988241010

Software

Market Closed - Toronto S.E. Other stock markets 03:59:59 2024-06-14 pm EDT			5-day change	1st Jan Change
4.21 ^CAD	0.00%		-2.55%	+38.03%

May. 09	Transcript : Kneat.com, inc., Q1 2024 Earnings Call, May 09, 2024
May. 08	Kneat.com, inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Kneat com : Sponsors European Biomanufacturing Summit

February 04, 2022 at 12:56 pm EST

European Biomanufacturing Summit

The European Biomanufacturing Summit takes place virtually from 8th-10th February 2022.

The themes for the event include leadership strategies, manufacturing & technology, quality & compliance, and supply chain & logistics. Event features such as live-streamed sessions, a virtual exhibit hall, digital chat rooms, and curated 1-2-1 meetings enable Generis to offer the same caliber of executive experience in a virtual setting. Kneat Solutions is delighted to be an official sponsor of this event, come visit us and chat with our validation experts. We look forward to seeing you there!

Attachments

Original Link
Original Document
Permalink

Disclaimer

Kneat.com Inc. published this content on 04 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 February 2022 17:55:06 UTC.

Latest news about kneat.com, inc.

Transcript : Kneat.com, inc., Q1 2024 Earnings Call, May 09, 2024	May. 09
Kneat.com, inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
Kneat Brief: Q1 2024 total revenue reaches $10.8 million, an increase of 35% year over year	May. 08	MT
North American Morning Briefing : Stock Futures Drift as Another Central Bank Moves Ahead of the Fed	May. 08	DJ
Global Healthcare Leader Selects Kneat	Feb. 28	CI
Kneat.com Maintained at Buy at Stifel GMP After Q4 Results; Price Target Raised to C$4.15	Feb. 23	MT
Transcript : Kneat.com, inc., Q4 2023 Earnings Call, Feb 22, 2024	Feb. 22
Kneat.com, inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 21	CI
Kneat Brief: Total revenues increased 35% to $9.8 million in Q4 of 2023, compared to $7.3 million for Q4 2022	Feb. 21	MT
North American Morning Briefing : Stock Futures -2-	Feb. 21	DJ
Kneat.com Maintained at Buy at Stifel GMP Following Bought-Deal Offering; Price Target Raised to C$4.00	Feb. 15	MT
Toronto Stocks Advance as BOC Holds Rates at 5%, BlackBerry Falls on Convertible Note Offering	Jan. 24	DJ
Kneat Upsized Previously Announced Bought Deal Public Offering to $17.4 Million	Jan. 24	MT
Kneat Brief: Upsized Previously Announced Bought Deal Public Offering to $17.4 Million	Jan. 24	MT
Kneat Announces $15.0 Million Bought Deal Public Offering; Earlier Signed Three-year Master Services Agreement With Global Consumer Products Leader; No Financials Given	Jan. 23	MT
Kneat Brief: Announcing $15.0 Million Bought Deal Public Offering	Jan. 23	MT
Kneat Signs Three-year Master Services Agreement With Global Consumer Products Leader; No Financials Given	Jan. 23	MT
Kneat.Com, Inc. Signs Three-Year Master Services Agreement	Jan. 23	CI
Kneat Brief: Says Signed a three-year Master Services Agreement with a Global Consumer products leader; No Financial Details Given	Jan. 23	MT
Kneat Says Global Consumer Healthcare Leader Selected It to Digitize Its Equipment Commissioning and Qualification Process Across More Than 25 Global Sites	Nov. 27	MT
Kneat Brief: Says Global Consumer Healthcare Leader Selecte Kneat to digitize its equipment Commissioning and Qualification process across more than 25 global site	Nov. 27	MT
Global Consumer Healthcare Leader Selects kneat.com, inc	Nov. 27	CI
Transcript : Kneat.com, inc., Q3 2023 Earnings Call, Nov 09, 2023	Nov. 09
Kneat.com Third-Quarter Loss Widens Even as Revenue Rises by 46%	Nov. 08	MT
Kneat.com, inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI

Chart kneat.com, inc.

Duration

Period

More charts

Company Profile

kneat.com, inc. develops and markets the Kneat Gx software-as-a-service (SaaS) platform. It designs, develops and supplies software for data and document management within regulated environments. The Companyâs focus is to service the facilities, equipment and computer systems (CSV) validation market initially within the global life sciences industry. The Companyâs product is Kneat Gx, a configurable, off-the-shelf application focused on validation lifecycle management and testing primarily within the life sciences industry. Kneat Gx provides a compliant digital solution that enables companies in the life sciences industry to become efficient and compliant with an automated process that has traditionally been manual, inefficient and paper-based. Its various validation processes include electronic logbook management, analytical instrument validation, utility and facility validation, process validation, method validation and equipment validation, cold chain validation, and others.

Sector

Software

Calendar

2024-08-05 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for kneat.com, inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

4.21 CAD

Average target price

4.933 CAD

Spread / Average Target

+17.18%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Enterprise Software

	1st Jan change	Capi.
KNEAT.COM, INC.	+38.03%	262M
ORACLE CORPORATION	+31.02%	380B
SAP SE	+27.09%	217B
SERVICENOW, INC.	+3.13%	150B
CONSTELLATION SOFTWARE INC.	+15.67%	58.58B
FAIR ISAAC CORPORATION	+19.47%	34.36B
HUBSPOT, INC.	+0.72%	29.8B
MICROSTRATEGY INCORPORATED	+136.78%	26.53B
WISETECH GLOBAL LIMITED	+22.36%	21.03B
SAGE GROUP PLC	-9.68%	13.39B

Enterprise Software

kneat.com, inc.

Equities

KSI

CA4988241010

Software

Kneat com : Sponsors European Biomanufacturing Summit

EPS Revisions